Hemagen Diagnostics, Inc.
HMGN
$0.00
$0.000.00%
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Net Income | 42.18% | -174.64% | 33.50% | -100.11% | -265.63% |
| Total Depreciation and Amortization | -17.57% | -15.37% | -6.40% | -7.45% | 6.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.89% | 45.98% | -24.00% | 53.13% | 136.04% |
| Change in Net Operating Assets | -80.71% | 121.06% | -61.24% | -50.30% | 460.23% |
| Cash from Operations | -178.15% | 105.00% | 8.04% | -421.79% | 164.36% |
| Capital Expenditure | 78.95% | -96.20% | -260.00% | -119.32% | 69.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -100.00% | -33.33% | 0.00% |
| Cash from Investing | -110.17% | -134.75% | -113.51% | -229.13% | 1,411.11% |
| Total Debt Issued | -- | -50.06% | 64.47% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -50.06% | 64.47% | -- | -- |
| Foreign Exchange rate Adjustments | 113.84% | -254.88% | 70.71% | -140.12% | -386.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,208.11% | 122.79% | 59.25% | -285.61% | 105.29% |
